Soranib - Sorafenib
Soranib - Sorafenib is a small molecular
inhibitor of several tyrosine protein kinases. Soranib used for the
treatment of cancerous cell formations in the kidney. It is also used to
treat unresectable hepatocellular carcinoma which is a type of liver cancer
that cannot be treated with surgery. Soranib belongs to the class of
multikinase inhibitors and slows down the growth of the cancerous cells.
Soranib is used for the treatment of primary kidney cancer
(advanced renal cell carcinoma) and advanced primary liver cancer
200 mg tablets.
Cipla Ltd. (INDIA)
Soranib is a prescription drug and should be used under proper medical
guidance and advice.